Nigeria

Resilience System


You are here

The U.S. FDA is poised to approve multiple RSV vaccines this year.

Primary tabs

Roughly six decades after the first attempt to develop a vaccine for respiratory syncytial virus, the Food and Drug Administration is poised to approve several shots by next winter.

No RSV vaccine has ever been approved in the U.S. The FDA is reviewing two applications — a vaccine from Pfizer and another from GlaxoSmithKline, both of which are for people ages 60 and up.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -
howdy folks
Page loaded in 1.580 seconds.